Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (85)

2024

  1. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  2. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 5

  4. Human gut microbiota analysis of cystic fibrosis infants using metaproteomics

    Microbiology Resource Announcements, Vol. 13, Núm. 6

  5. New materials and complications of prostheses in humans: situation in Spain

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 5, pp. 369-386

  6. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 9, pp. 2132-2141

  7. TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation

    EMBO Journal, Vol. 43, Núm. 13, pp. 2789-2812

  8. [Translated article] Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services

    Farmacia Hospitalaria, Vol. 48, pp. TS28-TS34

2023

  1. Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing

    Enfermedades Infecciosas y Microbiologia Clinica

  2. An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)

    Frontiers in Microbiology, Vol. 14

  3. Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

    Antibiotics, Vol. 12, Núm. 3

  4. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  5. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  6. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  7. Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528] (Redox Biology (2020) 34, (S2213231720304882), (10.1016/j.redox.2020.101528))

    Redox Biology

  8. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

    Neurology: Genetics, Vol. 9, Núm. 4

2022

  1. Critical Care in SARS‐CoV‐2 Infected Pregnant Women: A Prospective Multicenter Study

    Biomedicines, Vol. 10, Núm. 2

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Protocolo de validación de la herramienta de desprescripción LESS-CHRON en pacientes pluripatológicos. Proyecto LESS-CHRON-VALIDATION

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 5, pp. 311-315

  4. Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis

    Microbiology Spectrum, Vol. 10, Núm. 6